Published in Pharmacoeconomics on January 01, 2004
Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain. Eur J Health Econ (2007) 1.13
The NICE reference case requirement: more pain for what, if any, gain? Pharmacoeconomics (2004) 0.75
Health economic evaluation of non-melanoma skin cancer and actinic keratosis. Pharmacoeconomics (2004) 0.88
A retrospective analysis of costs and patterns of treatment for external genital warts in The Netherlands. Clin Ther (2002) 0.85
Modeling for health care and other policy decisions: uses, roles, and validity. Value Health (2002) 0.75